Larissa DeDea, PharmD, BCPS, PA-C

Larissa DeDea, PharmD, BCPS, PA-C, completed a pharmacy practice residency at Gallup Indian Medical Center, Gallup, New Mexico, and has worked on the Navajo Reservation as a pharmacist for the Public Health Service. In addition to being board-certified in pharmacotherapy, she is a graduate of the Yale University PA Program.

Recent Articles

Prescribing opioids safely in  patients with an opiate allergy

January 09, 2012

IgE-mediated allergy to opioids is rare but life-threatening, so distinguishing between a true allergic reaction and side effects to a previously prescribed opioid is crucial.

How should extravasation  injuries be treated?

December 07, 2011

Most extravasation injuries do not result in significant harm, but prompt recognition and early treatment are crucial.

Starting levothyroxine therapy; treating pernicious anemia

October 26, 2011

This month's topics are how to initiate treatment in patients with hypothyroidism and cobalamin dosing in patients with pernicious anemia.

Simvastatin dosing restrictions; monitoring amiodarone therapy

September 20, 2011

This month's topics are preventing myopathies when using simvastatin and safe use of amiodarone.

Erythromycin for GI motility;  sunscreens; enoxaparin in obesity

August 17, 2011

This month's topics are using erythromycin for GI motility, choosing a sunscreen, and DVT prophylaxis with enoxaparin in obese patients.

Tapentadol for pain; enoxaparin after prosthetic valve replacement

July 15, 2011

This month's topics are the new opioid analgesic tapentadol and using enoxaparin after prosthetic valve surgery.

Comparing brand name drugs  to their generic equivalents

June 09, 2011

Are generic products truly equivalent to their brand name counterparts, particularly narrow therapeutic index (NTI) medications such as antiepileptics, immunosuppressants, anticoagulants, and levothyroxine?